Albrecht Stenzinger, MD
Albrecht Stenzinger, MD
Institute of Pathology, University Hospital Heidelberg, Germany
Bestätigte E-Mail-Adresse bei med.uni-heidelberg.de
Titel
Zitiert von
Zitiert von
Jahr
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
8262013
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma …
A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ...
Journal of clinical oncology 30 (13), 1438-1446, 2012
4942012
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
TA Chan, M Yarchoan, E Jaffee, C Swanton, SA Quezada, A Stenzinger, ...
Annals of Oncology 30 (1), 44-56, 2019
3552019
Detection and segmentation of cell nuclei in virtual microscopy images: a minimum-model approach
S Wienert, D Heim, K Saeger, A Stenzinger, M Beil, P Hufnagl, M Dietel, ...
Scientific reports 2, 503, 2012
2182012
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ...
Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012
1982012
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
N Ertych, A Stolz, A Stenzinger, W Weichert, S Kaulfuß, P Burfeind, ...
Nature cell biology 16 (8), 779-791, 2014
1352014
The landscape of metastatic progression patterns across major human cancers
J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ...
Oncotarget 6 (1), 570, 2015
1272015
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
EM Noll, C Eisen, A Stenzinger, E Espinet, A Muckenhuber, C Klein, ...
Nature medicine 22 (3), 278-287, 2016
1232016
KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology
W Weichert, C Schewe, A Lehmann, C Sers, C Denkert, J Budczies, ...
The Journal of Molecular Diagnostics 12 (1), 35-42, 2010
1202010
Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, ...
British journal of cancer 109 (10), 2665-2674, 2013
1092013
Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with …
V Endris, R Penzel, A Warth, A Muckenhuber, P Schirmacher, ...
The Journal of molecular diagnostics 15 (6), 765-775, 2013
1002013
mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours
A Kasajima, M Pavel, S Darb-Esfahani, A Noske, A Stenzinger, H Sasano, ...
Endocrine-related cancer 18 (1), 181, 2011
992011
Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway
B Goeppert, C Konermann, CR Schmidt, O Bogatyrova, L Geiselhart, ...
Hepatology 59 (2), 544-554, 2014
952014
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
T Hristozova, R Konschak, C Stromberger, A Fusi, Z Liu, W Weichert, ...
Annals of oncology 22 (8), 1878-1885, 2011
922011
ROS1 expression and translocations in non‐small‐cell lung cancer: clinicopathological analysis of 1478 cases
A Warth, T Muley, H Dienemann, B Goeppert, A Stenzinger, PA Schnabel, ...
Histopathology 65 (2), 187-194, 2014
902014
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
A Warth, J Cortis, A Soltermann, M Meister, J Budczies, A Stenzinger, ...
British journal of cancer 111 (6), 1222-1229, 2014
882014
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
A Warth, A Stenzinger, AC von Brünneck, B Goeppert, J Cortis, I Petersen, ...
European respiratory journal 40 (5), 1221-1227, 2012
872012
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
A Warth, R Penzel, H Lindenmaier, R Brandt, A Stenzinger, E Herpel, ...
European Respiratory Journal 43 (3), 872-883, 2014
852014
Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab–docetaxel treatment
I Tinhofer, K Klinghammer, W Weichert, M Knödler, A Stenzinger, T Gauler, ...
Clinical Cancer Research 17 (15), 5197-5204, 2011
852011
A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
AL Volckmar, H Sültmann, A Riediger, T Fioretos, P Schirmacher, ...
Genes, Chromosomes and Cancer 57 (3), 123-139, 2018
832018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20